Evidence map›Paper›PMID 38352333›Full record

ArticlebioRxiv : the preprint server for biology2024

Pediatric human nose organoids demonstrate greater susceptibility, epithelial responses, and cytotoxicity than adults during RSV infection.

Gina M Aloisio, Divya Nagaraj, Ashley M Murray, Emily M Schultz, Trevor McBride, Letisha Aideyan, Erin G Nicholson, David Henke, Laura Ferlic-Stark, Anubama Rajan and 7 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Gina M AloisioDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Divya NagarajDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Ashley M MurrayDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Emily M SchultzDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Trevor McBrideDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Letisha AideyanDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Erin G NicholsonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
David HenkeDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Laura Ferlic-StarkDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Anubama RajanDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Amal KambalDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Hannah L JohnsonAdvanced Technology Cores, Baylor College of Medicine, Houston, Texas, USA.
Elina MosaAdvanced Technology Cores, Baylor College of Medicine, Houston, Texas, USA.
Fabio StossiAdvanced Technology Cores, Baylor College of Medicine, Houston, Texas, USA.
Sarah E BluttDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Pedro A PiedraDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Vasanthi AvadhanulaDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Baylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal DiseaseU19AI144297 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MARESSO, ANTHONY W · 2019 to 2024
$30.1M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Casey W Wright · 2019 to 2026
$14.7M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PIEDRA, PEDRO A · 2015 to 2025
$13.2M
ACQUISITION OF THE YOKOGAWA CV8000 HIGH THROUGHPUT SPINNING DISK MICROSCOPE AND ROBOTICSS10OD030414 · OD · BAYLOR COLLEGE OF MEDICINE · PI MANCINI, MICHAEL A. · 2022 to 2022
$1.4M
NCI NIH HHS P30 CA125123NIAID NIH HHS U19 AI116497NIAID NIH HHS U19 AI144297NIDDK NIH HHS P30 DK056338NIEHS NIH HHS P30 ES030285NIH HHS S10 OD030414
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is a common cause of respiratory infections, causing significant morbidity and mortality, especially in young children. Why RSV infection in children is more severe as compared to healthy adults is not fully understood. In the present study, we infect both pediatric and adult human nose organoid-air liquid interface (HNO-ALIs) cell lines with two contemporary RSV isolates and demonstrate how they differ in virus replication, induction of the epithelial cytokine response, cell injury, and remodeling. Pediatric HNO-ALIs were more susceptible to early RSV replication, elicited a greater overall cytokine response, demonstrated enhanced mucous production, and manifested greater cellular damage compared to their adult counterparts. Adult HNO-ALIs displayed enhanced mucus production and robust cytokine response that was well controlled by superior regulatory cytokine response and possibly resulted in lower cellular damage than in pediatric lines. Taken together, our data suggest substantial differences in how pediatric and adult upper respiratory tract epithelium responds to RSV infection. These differences in epithelial cellular response can lead to poor mucociliary clearance and predispose infants to a worse respiratory outcome of RSV infection.

Identifiers

PMID38352333
PMCPMC10862794
OpenAlexW4391480709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.